The forecast for antibacterial medicine use in the Netherlands from 2024 to 2028 shows a constant rate of 9.5 units (Defined Daily Dosage) per thousand persons per day. The usage in 2023 stood at 9.5 units as well, indicating no variation year-on-year between 2023 and 2024. Over the last two years, the usage trend remained stable with no changes, and the CAGR over the last five years is 0%, highlighting a consistent pattern with no growth or decline.
Future trends to watch for include potential shifts in antibacterial resistance patterns which could impact consumption rates, emerging new antibacterial therapies possibly altering prescribing habits, and public health initiatives aimed at reducing the use of antibiotics to prevent resistance.
